11 / 23
allied
academies
Journal of Pharmacology and Therapeutic Research
Volume 1 Issue 1
Clinical Pharmacy 2017
Notes:
Page 23
December 07-09, 2017 | Rome, Italy
7
th
World Congress on
Clinical Pharmacy and Pharmacy Practice
Chinese centralized intravenous admixture
service (CIVAS): An emerging pharmaceutical
industry-survey of the recent advances of
CIVAS in China
Xianghong Liu
Shandong University, China
Purpose:
The results of the survey involving 97 centralized
intravenous admixture service (CIVAS) centers in China
are described to give a review of the recent advances of
Chinese CIVAS.
Methods:
103 CIVAS centers in first- or second-class
Chinese hospital settings were surveyed by e-mail
questionnaire.
Results:
In this survey, the response rate was 94% (97
centers responded). For the scale and output issues, large
CIVAS centers with daily output of more than 10 thousand
bags accounted for 10% while the per workbench and per
square meter output varied dramatically among different
centers. For personnel structure, 80% CIVAS centers
chose the combination model of pharmacy and nursing.
For CIVAS operation model, more than 80% centers
adopted the drug centralized compounding model.
Conclusion:
CIVAS centers are playing important roles in
Chinese hospital pharmacy and have developed into an
emerging pharmaceutical industry while the development
of Chinese CIVAS centers presents highly diversity. For
personnel structure, the pharmacy-nursing combination
model is recommended while the operation model should
be selected according to specific hospitals. Besides,
universal guidelines for CIVAS operation and personnel
training are urgently needed.
Biography
Xianghong Liu is a Professor in Pharmacy Intravenous Admixture Services, Qilu
Hospital, Shandong University, and China
liuxianghongzr@163.comXianghong Liu, J Pharmacol Ther Res 2017